![Cells | Free Full-Text | CD38, a Receptor with Multifunctional Activities: From Modulatory Functions on Regulatory Cell Subsets and Extracellular Vesicles, to a Target for Therapeutic Strategies Cells | Free Full-Text | CD38, a Receptor with Multifunctional Activities: From Modulatory Functions on Regulatory Cell Subsets and Extracellular Vesicles, to a Target for Therapeutic Strategies](https://www.mdpi.com/cells/cells-08-01527/article_deploy/html/images/cells-08-01527-g001.png)
Cells | Free Full-Text | CD38, a Receptor with Multifunctional Activities: From Modulatory Functions on Regulatory Cell Subsets and Extracellular Vesicles, to a Target for Therapeutic Strategies
Anti-Multiple Myeloma Activity of Nanobody-Based Anti-CD38 Chimeric Antigen Receptor T Cells | Molecular Pharmaceutics
![Inhibition of CD38 and supplementation of nicotinamide riboside ameliorate lipopolysaccharide‐induced microglial and astrocytic neuroinflammation by increasing NAD+ - Roboon - 2021 - Journal of Neurochemistry - Wiley Online Library Inhibition of CD38 and supplementation of nicotinamide riboside ameliorate lipopolysaccharide‐induced microglial and astrocytic neuroinflammation by increasing NAD+ - Roboon - 2021 - Journal of Neurochemistry - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/bcb7d575-b37c-47a1-bfa0-d954e3009f4e/jnc15367-fig-0009-m.jpg)
Inhibition of CD38 and supplementation of nicotinamide riboside ameliorate lipopolysaccharide‐induced microglial and astrocytic neuroinflammation by increasing NAD+ - Roboon - 2021 - Journal of Neurochemistry - Wiley Online Library
![Selective targeting of CD38 hydrolase and cyclase activity as an approach to immunostimulation - RSC Advances (RSC Publishing) DOI:10.1039/D1RA06266B Selective targeting of CD38 hydrolase and cyclase activity as an approach to immunostimulation - RSC Advances (RSC Publishing) DOI:10.1039/D1RA06266B](https://pubs.rsc.org/image/article/2021/RA/d1ra06266b/d1ra06266b-f2_hi-res.gif)
Selective targeting of CD38 hydrolase and cyclase activity as an approach to immunostimulation - RSC Advances (RSC Publishing) DOI:10.1039/D1RA06266B
![Cells | Free Full-Text | The Many Facets of CD38 in Lymphoma: From Tumor–Microenvironment Cell Interactions to Acquired Resistance to Immunotherapy Cells | Free Full-Text | The Many Facets of CD38 in Lymphoma: From Tumor–Microenvironment Cell Interactions to Acquired Resistance to Immunotherapy](https://www.mdpi.com/cells/cells-09-00802/article_deploy/html/images/cells-09-00802-g001.png)
Cells | Free Full-Text | The Many Facets of CD38 in Lymphoma: From Tumor–Microenvironment Cell Interactions to Acquired Resistance to Immunotherapy
![Targeting NAD+ Synthesis to Potentiate CD38-Based Immunotherapy of Multiple Myeloma: Trends in Cancer Targeting NAD+ Synthesis to Potentiate CD38-Based Immunotherapy of Multiple Myeloma: Trends in Cancer](https://www.cell.com/cms/attachment/2d058ad6-9222-4baf-b674-1084bea50242/gr1_lrg.jpg)
Targeting NAD+ Synthesis to Potentiate CD38-Based Immunotherapy of Multiple Myeloma: Trends in Cancer
Targeting Attenuated Interferon-α to Myeloma Cells with a CD38 Antibody Induces Potent Tumor Regression with Reduced Off-Target Activity | PLOS ONE
![Frontiers | The Multi-faceted Ecto-enzyme CD38: Roles in Immunomodulation, Cancer, Aging, and Metabolic Diseases Frontiers | The Multi-faceted Ecto-enzyme CD38: Roles in Immunomodulation, Cancer, Aging, and Metabolic Diseases](https://www.frontiersin.org/files/Articles/463666/fimmu-10-01187-HTML-r1/image_m/fimmu-10-01187-g001.jpg)
Frontiers | The Multi-faceted Ecto-enzyme CD38: Roles in Immunomodulation, Cancer, Aging, and Metabolic Diseases
![Frontiers | CD38 in Adenosinergic Pathways and Metabolic Re-programming in Human Multiple Myeloma Cells: In-tandem Insights From Basic Science to Therapy Frontiers | CD38 in Adenosinergic Pathways and Metabolic Re-programming in Human Multiple Myeloma Cells: In-tandem Insights From Basic Science to Therapy](https://www.frontiersin.org/files/Articles/432517/fimmu-10-00760-HTML/image_m/fimmu-10-00760-g001.jpg)
Frontiers | CD38 in Adenosinergic Pathways and Metabolic Re-programming in Human Multiple Myeloma Cells: In-tandem Insights From Basic Science to Therapy
![Upregulation of CD38 expression on multiple myeloma cells by novel HDAC6 inhibitors is a class effect and augments the efficacy of daratumumab | Leukemia Upregulation of CD38 expression on multiple myeloma cells by novel HDAC6 inhibitors is a class effect and augments the efficacy of daratumumab | Leukemia](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41375-020-0840-y/MediaObjects/41375_2020_840_Fig7_HTML.png)